EDGEWATER, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE GOG FOUNDATION INC, founded in 2002, is a mid-sized nonprofit in the Medical Research sector that reported $66.1M in total revenue in fiscal year 2023. Revenue decreased 16% compared to the prior year. Expenses of $63.9M left a modest 3% surplus.
THE GOG FOUNDATION, INC. (GOG FOUNDATION) IS A NONPROFIT ORGANIZATION WITH THE PURPOSE OF PROMOTING EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES, INCLUDING CANCERS THAT ARISE FROM THE OVARIES, UTERUS, CERVIX, VAGINA, AND VULVA. OUR INSTITUTIONS AND INVESTIGATORS ARE ESSENTIAL CONTRIBUTORS TO ADVANCEMENTS IN TREATMENT REGIMENS, SURGICAL PROCEDURES, QUALITY OF LIFE ANALYSES, AND PREVENTION KNOWLEDGE. THE RESULTS OF GOG FOUNDATION CLINICAL TRIALS HAVE INFLUENCED THE STANDARD OF CARE FOR NUMEROUS MALIGNANT GYNECOLOGIC NEOPLASMS. THE MISSION OF THE GOG FOUNDATION IS TO CONDUCT CLINICAL AND TRANSLATIONAL RESEARCH THAT POSITIVELY IMPACTS WOMEN THROUGH THE PREVENTION AND TREATMENT OF GYNECOLOGIC MALIGNANCIES. THE VISION OF THE GOG FOUNDATION IS TO BE THE PREMIER COLLABORATIVE NETWORK FOR TRANSFORMATIVE RESEARCH IN GYNECOLOGIC MALIGNANCIES.
THE FOUNDATION IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN...
THE FOUNDATION IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. IN 2023 THE GOG FOUNDATION, INC. CONDUCTED CLINICAL TRIALS THROUGH OUR 300 PLUS INSTITUTIONS. THESE EXPENSES INCLUDED PROTOCOL DEVELOPMENT, REGULATORY AFFAIRS, MEETINGS TO REVIEW TRIAL DATA, TRIAL DEVELOPMENT THROUGH COMMITTEE FUNCTIONS AND OTHER INDIRECT RELATED EXPENSES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $66,124,814 | $78,963,515 | -0.2% |
| Expenses | $63,899,174 | $77,876,182 | -0.2% |
| Net Income | $2,225,640 | $1,087,333 | +1.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| MARY SHARP | CHIEF FINANCIAL OFFICER | 35.00 |
Officer
|
$313,565 | $65,595 | $379,160 |
| MICHAEL S POWERS | GENERAL COUNSEL | 35.00 |
Key Emp
|
$299,030 | $46,606 | $345,636 |
| LAURA L REESE | EXECUTIVE DIRECTOR, OPERATIONS | 35.00 |
Officer
|
$280,179 | $60,587 | $340,766 |
| JENNIFER T KIEN | EXECUTIVE DIRECTOR, BUSI. DEV. | 35.00 |
Key Emp
|
$247,201 | $67,827 | $315,028 |
| NICOLE M LAMACK | SR. DIR., GRANTS, ACCT., SITE CONTRACTS | 35.00 |
Highest
|
$176,494 | $44,909 | $221,403 |
| WENDY WELLS | DIRECTOR OF FINANCE | 35.00 |
Highest
|
$165,451 | $54,651 | $220,102 |
| NOLA R BENCZE | COMPLIANCE ATTORNEY | 35.00 |
Highest
|
$172,422 | $45,061 | $217,483 |
| HEATHER LANKES | DIRECTOR, TRANSLATIONAL RESEARCH | 35.00 |
Highest
|
$167,852 | $43,287 | $211,139 |
| JOSH J KILLION | DIRECTOR, INFORMATION TECHNOLOGY | 35.00 |
Highest
|
$173,169 | $35,045 | $208,214 |
| KATHLEEN E CAMPBELL-SIMMS | EXEC. DIR., CLINICAL TRIALS MNGT. | 35.00 |
Key Emp
|
$171,783 | $32,043 | $203,826 |
| THOMAS J HERZOG MD | PRESIDENT | 20.00 |
Officer
Director
|
$50,000 | $0 | $50,000 |
| LARRY J COPELAND MD | IMMEDIATE PAST PRESIDENT | 20.00 |
Officer
Director
|
$50,000 | $0 | $50,000 |
| ROBERT S MANNEL MD | SR. VICE PRESIDENT/CHAIR | 13.00 |
Officer
Director
|
$33,000 | $0 | $33,000 |
| CAROL AGHAJANIAN MD | VICE PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| BRADLEY J MONK MD | VICE PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KATHLEEN N MOORE MD | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| DAVID G MUTCH MD | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| ROBERT L COLEMAN MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| PAUL A DISILVESTRO MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| TASHANNA MYERS MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| ALEXANDER B OLAWAIYE MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID O'MALLEY MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| LESLIE M RANDALL MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| ANGELES A SECORD MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| BRIAN SLOMOVITZ MD | DIRECTOR-AT-LARGE | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $66,124,814 | $63,899,174 | $125,267,390 | $2,225,640 |
| 2022 | $78,963,515 | $77,876,182 | $121,695,813 | $1,087,333 |
| 2021 | $71,071,681 | $60,658,790 | $118,907,888 | $10,412,891 |
| 2020 | $51,133,816 | $50,362,214 | $96,851,330 | $771,602 |
| 2019 | $47,593,751 | $36,958,338 | $83,724,373 | $10,635,413 |
| 2018 | $32,691,741 | $33,180,624 | $75,412,609 | $-488,883 |
Compare THE GOG FOUNDATION INC with other nonprofits in Maryland and across the country.